OlympiA: Adjuvant olaparib delays recurrence of BRCA-mutant breast cancer | Judy Garber

Описание к видео OlympiA: Adjuvant olaparib delays recurrence of BRCA-mutant breast cancer | Judy Garber

Judy Garber reports on the phase 3 OlympiA study suggesting that adjuvant olaparib could be an option for the treatment of patients with early-stage breast cancer and germline BRCA variants (5:00).

View more on Medicine Matters oncology: https://bit.ly/3fMzOa9

Комментарии

Информация по комментариям в разработке

Похожие видео